Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLN) Assets Average: 2025

Historic Assets Average for Silence Therapeutics (SLN) over the last 2 years, with Sep 2025 value amounting to $626.6 million.

  • Silence Therapeutics' Assets Average was N/A to $626.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $626.6 million, marking a year-over-year change of. This contributed to the annual value of $161.0 million for FY2024, which is N/A change from last year.
  • Silence Therapeutics' Assets Average amounted to $626.6 million in Q3 2025, which was up 33.16% from $470.5 million recorded in Q2 2025.
  • Silence Therapeutics' 5-year Assets Average high stood at $626.6 million for Q3 2025, and its period low was $119.4 million during Q1 2024.